Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0386 | 0.1415 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0386 | 0.1415 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0386 | 0.1415 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0386 | 0.1415 | 0.5 |
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.0386 | 0.1415 | 0.5 |
Schistosoma mansoni | dopamine-beta-monooxygenase | 0.073 | 0.3906 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0196 | 0.0042 | 0.0294 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.0386 | 0.1415 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.